+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cancer Microbiome Sequencing Market - Global Forecast 2025-2030- Product Image
Cancer Microbiome Sequencing Market - Global Forecast 2025-2030- Product Image
Sale

Cancer Microbiome Sequencing Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010625
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cancer microbiome sequencing market is rapidly evolving, driven by innovation in sequencing platforms, advanced bioinformatics, and shifting global dynamics. For senior decision-makers, understanding how these forces reshape oncology research and clinical practice is essential for actionable strategy in a complex, highly segmented sector.

Market Snapshot: Cancer Microbiome Sequencing Market Overview

The Cancer Microbiome Sequencing Market grew from USD 1.84 billion in 2024 to USD 1.95 billion in 2025. It is expected to continue growing at a CAGR of 5.89%, reaching USD 2.59 billion by 2030. This robust pace reflects increased adoption of precision oncology approaches, ongoing sequencing innovation, and greater awareness of how the microbiome impacts cancer management.

Scope & Segmentation: Comprehensive Coverage Across Technologies and Applications

  • Technology: 16S rRNA sequencing, shotgun metagenomic sequencing, and whole genome sequencing platforms form the core of industry adoption, each offering unique depth and insight into the tumor-associated microbiome.
  • Application: Key cancer focus areas include breast cancer, colorectal cancer, and lung cancer, with each presenting distinct microbial signatures and clinical significance.
  • Workflow: Segments span analytical processes (Illumina, Oxford Nanopore, PacBio sequencing), bioinformatics (functional, statistical, taxonomic analysis tools), and pre-analytical activities that define sample processing quality and consistency.
  • End User: The market encompasses hospitals and clinics, pharmaceutical and biotechnology companies, as well as research institutes—each leveraging microbiome sequencing to meet research, diagnostic, or therapeutic objectives.
  • Sample Type: Stratification by blood, fecal, and tissue samples enables highly targeted biomarker discovery and supports diverse clinical and translational applications.
  • Region: Coverage extends across the Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe and the Middle East & Africa (featuring leading countries such as the United Kingdom, Germany, France, and several others), and Asia-Pacific, spotlighting emerging hubs in China, Japan, India, Australia, and more.
  • Company Landscape: The study provides comparative trend analysis for innovators and established leaders including Illumina, Thermo Fisher Scientific, Roche Holding, BGI Genomics, QIAGEN, Pacific Biosciences, Oxford Nanopore Technologies, Agilent Technologies, Eurofins Scientific, and Danaher Corporation.

Key Takeaways for Senior Decision-Makers

  • Rapid advancement in sequencing technologies is expanding the resolution and functional relevance of cancer microbiome datasets, informing how clinicians and researchers approach biomarker discovery.
  • AI-powered bioinformatics and integrated analytical pipelines are transforming data interpretation, enabling multiomic insights and accelerating the path from discovery to actionable findings.
  • Collaborative models between industry, diagnostics partners, and academic consortia are shifting the competitive landscape, fostering robust clinical validation and accelerating assay development.
  • Shifts in regulatory recognition and reimbursement frameworks are directly influencing adoption and driving investment in clinically validated assays and direct-to-lab solutions.
  • Segmentation by technology use, sample origin, and cancer type is increasing the relevance and effectiveness of clinical applications and R&D pipelines.
  • Manufacturers and end users are reassessing operational strategies in light of supply chain constraints and changing economic factors, underscoring the importance of flexible sourcing and regional partnership development.

Cancer Microbiome Sequencing Market: Tariff Impact and Supply Chain Considerations

U.S. tariff reforms introduced in 2025 have created complex challenges for sequencing reagent and instrument providers. Increased import duties have pushed operational costs higher, impacting clinical laboratories and research settings. Stakeholders are responding by building domestic manufacturing partnerships, reorganizing supplier networks, and exploring nearshoring for critical workflow elements. These strategic shifts are redefining supply chain resilience and cost management within the cancer microbiome sequencing ecosystem.

Methodology & Data Sources

This report combines in-depth interviews with industry experts, comprehensive review of scientific literature and regulatory filings, and benchmarking against peer platforms. Quantitative analysis of sequencing platforms, reagent use, and supplier feedback is validated through expert workshops, ensuring reliable, actionable insights underpin every conclusion.

Why This Report Matters to Senior Leaders

  • Enables strategic planning by clarifying how segmentation, regional trends, and technology adoption shape market opportunities and risks.
  • Supports evidence-based investment in innovation, allowing leaders to benchmark their capabilities and explore new clinical and operational models.
  • Facilitates agile response to supply chain or regulatory disruptions, with direct implications for business continuity and growth in the cancer microbiome sequencing market.

Conclusion

Advances in sequencing and bioinformatics are redefining cancer microbiome research, opening new avenues for diagnostics and therapy. Decision-makers who embrace strategic insights and adapt to shifting market realities will lead the next phase of oncology innovation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of multi-omics microbiome sequencing for personalized cancer therapy guidance and biomarker discovery
5.2. Advances in AI-driven microbiome data analytics enhancing tumor microenvironment profiling accuracy
5.3. Emergence of non-invasive liquid biopsy microbiome assays for early cancer detection and monitoring
5.4. Development of standardized protocols for cancer microbiome sample collection to improve reproducibility
5.5. Growth of partnerships between biotech firms and research institutes to accelerate microbiome-based drug development
5.6. Regulatory frameworks evolving to address microbiome sequencing diagnostic approvals and data privacy challenges
5.7. Adoption of shotgun metagenomic sequencing over 16S rRNA for comprehensive tumor-associated microbiota characterization
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cancer Microbiome Sequencing Market, by Technology
8.1. Introduction
8.2. 16S Rrna Sequencing
8.3. Shotgun Metagenomic Sequencing
8.4. Whole Genome Sequencing
9. Cancer Microbiome Sequencing Market, by Application
9.1. Introduction
9.2. Breast Cancer
9.3. Colorectal Cancer
9.4. Lung Cancer
10. Cancer Microbiome Sequencing Market, by Workflow
10.1. Introduction
10.2. Analytical
10.2.1. Illumina Sequencing
10.2.2. Oxford Nanopore Sequencing
10.2.3. Pacbio Sequencing
10.3. Bioinformatics
10.3.1. Functional Analysis Tools
10.3.2. Statistical Analysis Tools
10.3.3. Taxonomic Profiling Tools
10.4. Pre Analytical
11. Cancer Microbiome Sequencing Market, by End User
11.1. Introduction
11.2. Hospitals And Clinics
11.3. Pharmaceutical And Biotechnology Companies
11.4. Research Institutes
12. Cancer Microbiome Sequencing Market, by Sample Type
12.1. Introduction
12.2. Blood Samples
12.3. Fecal Samples
12.4. Tissue Samples
13. Americas Cancer Microbiome Sequencing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cancer Microbiome Sequencing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cancer Microbiome Sequencing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Illumina, Inc.
16.3.2. Thermo Fisher Scientific, Inc.
16.3.3. Roche Holding AG
16.3.4. BGI Genomics Co., Ltd.
16.3.5. QIAGEN N.V.
16.3.6. Pacific Biosciences of California, Inc.
16.3.7. Oxford Nanopore Technologies Ltd.
16.3.8. Agilent Technologies, Inc.
16.3.9. Eurofins Scientific SE
16.3.10. Danaher Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CANCER MICROBIOME SEQUENCING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CANCER MICROBIOME SEQUENCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CANCER MICROBIOME SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CANCER MICROBIOME SEQUENCING MARKET: RESEARCHAI
FIGURE 26. CANCER MICROBIOME SEQUENCING MARKET: RESEARCHSTATISTICS
FIGURE 27. CANCER MICROBIOME SEQUENCING MARKET: RESEARCHCONTACTS
FIGURE 28. CANCER MICROBIOME SEQUENCING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CANCER MICROBIOME SEQUENCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ILLUMINA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ILLUMINA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY OXFORD NANOPORE SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY OXFORD NANOPORE SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PACBIO SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PACBIO SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY FUNCTIONAL ANALYSIS TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY FUNCTIONAL ANALYSIS TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY STATISTICAL ANALYSIS TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY STATISTICAL ANALYSIS TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TAXONOMIC PROFILING TOOLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TAXONOMIC PROFILING TOOLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PRE ANALYTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PRE ANALYTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY FECAL SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY FECAL SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 102. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 103. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 104. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 105. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 106. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 107. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 110. CANADA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 111. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 116. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 117. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 118. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 124. MEXICO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 183. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 188. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 189. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 190. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 191. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 192. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 193. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 196. GERMANY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 197. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 202. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 203. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 204. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 205. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 206. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 207. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 210. FRANCE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 225. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 230. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 231. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 232. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 233. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 234. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 235. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 238. ITALY CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 239. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 244. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 245. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 246. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 247. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 248. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 249. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 252. SPAIN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 295. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 296. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 297. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 300. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
TABLE 301. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2024 (USD MILLION)
TABLE 302. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2025-2030 (USD MILLION)
TABLE 303. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2024 (USD MILLION)
TABLE 304. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2025-2030 (USD MILLION)
TABLE 305. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 308. DENMARK CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS CANCER MICROBIOME SEQUEN

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Cancer Microbiome Sequencing market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Roche Holding AG
  • BGI Genomics Co., Ltd.
  • QIAGEN N.V.
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • Danaher Corporation

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.95 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.59 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Microbiome Sequencing Services Market - Global Forecast 2025-2030 - Product Image

Microbiome Sequencing Services Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Microbiome Sample Preparation Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Microbiome Sample Preparation Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Microbiome Sample Preparation Technology Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables), Workflow, Application, Disease, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Microbiome Sample Preparation Technology Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables), Workflow, Application, Disease, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Microbiome Diagnostics Market - Global Forecast 2025-2030 - Product Image

Microbiome Diagnostics Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Microbiome Diagnostics - Global Strategic Business Report - Product Image

Microbiome Diagnostics - Global Strategic Business Report

  • Report
  • 569 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.